
Why NHS fat jab rollout won't solve UK obesity crisis – but YOU will still end up paying as yo-yo porkers get hooked
TRUST me, I'm not a doctor.
But as the first national newspaper journalist to investigate fat jabs, (and, in so doing, vomit in a Waitrose bag for life on a packed commuter train) I DO know what I'm talking about.
10
So believe me, the mass roll-out of weight-loss jabs isn't the great health revolution Big Pharma promises. The only true victors, at present, are Big Pharma.
The plan to let GPs prescribe Mounjaro to those with a BMI over 40 and at least four other health problems — such as Type 2 diabetes or high blood pressure — is whacking a plaster on a severed arm.
Or, indeed, a safety pin on the bulging seams of a fatty's waistband.
These are miracle drugs. But they address the problem, NOT the cause.
And obesity, as so many will testify, is as much an emotional problem as physical. Where is the help for people who use food as a crutch? No one chooses to stuff themselves with doughnuts 24/7.
Unless there's a longer-term strategy, one prioritising prevention over quick-fix cure, we shall go from being a nation of porkers to a nation of yo-yo porkers; 'healthy' one month, obese again five months after the jabs have stopped.
In other words, the majority of people will need to be on them for life. (Or 'lifers', as one celeb WhatsApp group is named, consisting entirely of those micro-dosing Mounjaro).
GPs, who already claim they're overworked, won't have the time to give every patient a dedicated exercise and diet plan. Getting lean isn't a one-size-fits-all programme.
The fear, then, is that the grossly overweight will be able to plop on their sofas, merrily jabbing once a week — at taxpayer expense — waiting for the lard to drop off.
The same foods that got them here — invariably ultra-processed, fried — are still consumed. Just less of them.
That's not healthy — it is simply scratching that McDonald's itch with a Quarter Pounder instead of a Big Mac.
Natural desire
Unless people exercise concurrently, once the weight is off, they'll be left with uncomfortable excess skin.
In April 2023, during a trip to Los Angeles (where A-listers have been on Wegovy, Mounjaro and Ozempic since 2018) I tried out all three pens.
I wrote about the experience, warning of the deeply unpleasant side effects.
In five months I lost around 8kg, dropping to a tiny size 8.
I hadn't weighed so little since I was at university. I looked amazing, bar a touch of 'Ozempic Face'.
And — with the exception of Mounjaro for which there were blessedly few side effects — I felt horrific. I was sick, repeatedly (once, a nadir, under a table in First Class on a heaving rush hour train), once on a treadmill (jogging) and on one occasion I visibly retched while on a Zoom call to a Hollywood actress.
Plus my eyes went blurry, prompting a quick visit to Moorfields Eye Hospital.
'No pain no gain' has its limits.
Anyway, convinced I'd have entirely reprogrammed my brain — one that thinks about my next snack the very nanosecond it stirs in the morning — I came off them. And promptly shot up a dress size.
I write this as someone who knows how to eat, and goes to the gym come hell or hangover five days a week.
But still I battle daily my natural desire to smash a kilo of peanut butter and eat delicious olive-oily pasta daily.
Fat jabs are 100 per cent a miracle drug. But they do not address the emotional side of eating (or drinking) that so, so many Brits suffer with.
Of course there are exceptions: those who use the jabs positively to break the pattern, kick-starting a fantastic lifestyle overhaul. But they're the exceptions.
Unless we want a bunch of 'lifers', the NHS MUST use these drugs with caution, and start developing a weaning-off process.
At present, there is none. And that must change.
IT'S ALL WHITE NOW…
THREE months is a long time in showbusiness.
Back in spring, Rachel Zegler 's disastrous turn as Snow White – which saw her slagging off the original film for being 'weird' and sexist promptly after getting the million pound big break – had her on the verge of cancellation.
Today she's being feted on a daily basis, and lauded as the most exciting West End talent in decades.
Playing Evita at the London Palladium, each night huge crowds are gathering on the street to see this young superstar belt out Don't Cry For Me Argentina.
She is, by all accounts, mind-blowingly good.
MINISTERS spent more than £500,000 of taxpayers' money on a new makeover of the Government website.
And the 'makeover' in question?
10
From this . . .
To this . . .
Yep, the black to blue refresh, with a dot placed approx two millimetres higher up, is what your hard-earned dollar is paying for.
Cool.
SOUND POLICY
IDEA of the week.
Should Keir, Kemi or Nige fancy a guaranteed vote-winner, whack this on the next election manifesto.
Anyone caught playing music/TV/video games on their tablet/smartphone on public transport, minus headphones should receive an automatic prison sentence.
Genuinely, is there ANYTHING more annoying?
HOST'S RIGHT ON CUE
10
KUDOS to Martine Croxall.
The BBC News presenter calmly overrode the corporation's pathetically woke autocue, correcting it from a bulletin about 'pregnant people' to 'women'.
Martine is a previous winner of Celebrity Mastermind, which explains it.
Unlike the silly young fool who writes BBC News scripts.
MUCH kerfuffle surrounding the Assisted Dying Bill finally getting passed last week.
Why?
For me, it's really very simple. We treat our aged, ill and cherished pets with love, respect and kindness towards the end of life, we should do the same for ourselves.
It won't result in hundreds of thousands of dead-before-their-time OAP's being perfidiously wiped out by greedy grandkids; it will simply mean fewer people dying in greater pain.
TAKING CARE OF MYSELFIE
OBVIOUSLY I'm a sucker for a trend.
Like a lemming to a cliff edge, off I trot to try out what the cool kids do – which is how I stumbled upon the latest-ish TikTok fad for putting a selfie into Chat GPT and asking it what you'd look like under different circumstances.
So off I ventured, instructing my virtual friend to tell me what I'd look like in five years time if I 'smoked 40 a day' and 'didn't moisturise'. The results, as you can see, weren't pretty.
Next, I asked it how I'd fare if 'ate only whole foods, exercised five days a week, drank two litres of mineralised water, took weekly facials and had no stress in my life; the results were prettier, albeit somewhat insultingly it gave me an entirely new face.
Finally, I asked Chat GPT to show me 12 stone portlier – see for yourselves.
*Orders fat jab*
BRAT'S WAY TO DO IT
WHO says women's tennis isn't a patch on men's?
Russian-born Yulia Putintseva, aka the sport's biggest brat, who last year taunted a ball girl, got in another spat after her third round match against Maria Sakkari at the Bad Homberg Open.
After Putintseva refused to make eye contact while shaking hands, Sakkari told her to 'act like a human being', before adding, cuttingly: 'Nobody likes you'.
Ms Putintseva promptly told her opponent to 'go f***' herself.
Language which will go down a treat next week when Wimbledon starts.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
an hour ago
- Reuters
US Senator Cassidy urges delay of US vaccine discussion
June 23 (Reuters) - U.S. Senator Bill Cassidy, chair of the U.S. Senate Committee on Health, Education, Labor and Pensions called for U.S. vaccine advisers to delay a Wednesday meeting to discuss recommendations for vaccines. "Wednesday's meeting should not proceed with a relatively small panel, and no CDC Director in place to approve the panel's recommendations," Cassidy said in a post on X, referring to the Centers for Disease Control and Prevention. The CDC panel, known as the Advisory Committee on Immunization Practices, is scheduled to meet on June 25 and 26.


Daily Mirror
an hour ago
- Daily Mirror
GPs' strict rules for prescribing weight loss jab explained
GPs are now able to prescribe Mounjaro injections, but only if patients meet strict guidelines NHS England has announced that GPs will now be able to prescribe Mounjaro injections. Originally licensed for type 2 diabetes treatment, the medication's use as a weight loss aid stems from its appetite-suppressing properties. The health service aims to make these injections widely available, but this is a long-term objective. Starting on Monday, a very limited group of people will be able to get prescriptions for it through their GP. Currently, two criteria must be met to qualify for the prescription. Firstly, a BMI of 40 or over is required, however, if you're from a minority ethnic background, you may be eligible with a BMI of 37.5 or over. Additionally, you'll need to have been diagnosed with four out of the following five conditions: Type 2 diabetes High blood pressure Heart and vascular disease High cholesterol Obstructive sleep apnoea In this initial rollout, it's expected that 220,000 people will be eligible and receive Mounjaro through the NHS in the next three years, according to the Guardian. Previously, patients needed to use special weight loss services to access the medication. As weight loss medication became mainstream news, GP surgeries have reported being overwhelmed with requests for the injections. With these criteria now in the open, GPs are urging people not to approach their local surgery unless they meet the eligibility requirements, according to the BBC. BMI is calculated by comparing your height and weight, with ethnicity factored in for certain risk factors. It has faced criticism for not accounting for muscle mass, which could skew results, but remains the most common method for assessing obesity in healthcare. The NHS provides a complimentary BMI calculator online here. According to this tool, a BMI between 18.5 and 25 is deemed healthy, below 18.5 is underweight, 25 to 30 is overweight, and over 30 is considered obese. The NHS tool also suggests "next steps" for those whose BMI falls outside the healthy range. Even if you are eligible for the jabs, the early days of this rollout could lead to some hiccups as experts have already warned the supply set aside for GP prescriptions won't be enough to satisfy demand. Mounjaro also requires monthly follow-ups, demanding significant time and effort from medical professionals. As a result, GP surgeries will likely be strategising to ensure they don't exceed their capacity. In Wales, the government is deliberating on a primary care rollout, with the injections presently accessible only via specialist weight management services. Northern Ireland, meanwhile, is implementing a regional obesity management service. For people who don't qualify or live in regions where GPs aren't offering the treatment, Dr Xand offered reassurance on Morning Live: "If you think these drugs would help but you don't meet the criteria, I think it's worth saying there are lots of drugs in the pipeline, it is very likely that the price can come down. "It can be frustrating to have to wait. But I think over the next few years, the picture is optimistic for people who want these drugs."

Western Telegraph
an hour ago
- Western Telegraph
At-home tests offered to women to drive down cervical cancer cases
The tests, which can be performed at home, look for the human papillomavirus (HPV) – the virus which is linked to the majority of cases of cervical cancer. After getting the nod from the UK National Screening Committee in March, the NHS in England is going to offer the tests to certain women. It is expected that the rollout will begin in January next year. The NHS offers cervical screening tests – previously known as smear tests – to all women aged 25-64 every three years. But many people do not take up the offer, with a number citing a lack of time, discomfort or embarrassment. Data published by the NHS last November showed five million women are not up to date with routine check-ups. Now officials have said that at-home kits will be offered to women who have rarely or have never attended their cervical screening. The initiative will see women sent a self-sampling kit in the post which can be returned via pre-paid mail. Health Secretary Wes Streeting said the move could break down 'barriers that keep millions of women from potentially life-saving tests' (Lucy North/PA) People who were found to have the HPV virus will be encouraged to attend an in-person appointment with a clinician. Research has suggested that offering DIY testing kits could boost uptake. The YouScreen trial, which was led by King's College London in partnership with NHS England, found that offering self-sampling kits to 'under-screened' women when they attend their GP practice and by posting kits to women's homes could boost uptake in England by about 400,000 each year. The Department of Health and Social Care said the new approach could potentially save about 5,000 lives a year across England. It said that the new programme 'specifically targets those groups consistently missing vital appointments' including: younger women, those from minority ethnic backgrounds, people with disabilities and LGBT plus people. Health and Social Care Secretary Wes Streeting said: 'These self-sampling kits represent healthcare that works around people's lives, not the other way around. 'They put women firmly in control of their own health, ensuring we catch more cancers at their earliest, most treatable stages. 'Our 10-year health plan will fundamentally reform the NHS, shifting focus from treating illness to preventing it before it starts. 'We know the earlier cancer is diagnosed the better the chances are of survival. 'By making screening more convenient, we're tackling the barriers that keep millions of women from potentially life-saving tests.' Dr Anita Lim, chief investigator of the YouScreen trial from King's College London, added: 'This is a significant step forward for cervical cancer prevention and brings us closer to the NHS goal of eliminating the disease by 2040. 'The YouScreen trial, which provided self-sampling HPV kits to under-screen women in London, demonstrated that self-sampling could reach people who find it difficult to attend traditional screening – including those from diverse and underserved populations. 'It's hugely positive to see this now reflected in national policy, helping more people get protected from this highly preventable cancer.' Michelle Kane, NHS England's director of screening, added: 'There are a number of reasons that stop some women taking up the offer of screening and we hope the introduction of self-testing will encourage more women to take up this life-saving test in a way that works for them. 'I'd encourage anyone who gets an invite for a cervical screening, either from their local GP practice or the NHS App, to attend and if you have any worrying symptoms, please contact your GP. It could save your life.'